Lumos Pharma Inc (NASDAQ:LUMO)

7.87
Delayed Data
As of Apr 01
 -0.63 / -7.41%
Today’s Change
6.74
Today|||52-Week Range
32.40
-65.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues68.5M35.8M28.7M12.5M
 
 
 
 
 
Depreciation And Amortization1.6M2.1M1.4M1.1M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses100.5M112.8M98.5M72.5M
 
 
 
 
 
Research And Development71.4M82.2M69.3M45.2M
 
 
 
 
 
Total Operating Expenses102.1M114.9M99.9M73.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.6M-79.2M-71.2M-61.1M
 
 
 
 
 
Extraordinary Charge0.00-11.6M-1.7M-1.3M
 
 
 
 
Interest Expense On Debt105.0K22.0K119.0K52.0K
 
 
 
 
 
Other Expenses-14.0K32.0K-126.0K-102.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-33.6M-90.5M-72.5M-60.6M
 
 
 
 
 
Income Taxes-6.7M-5.4M-559.0K-7.0M
 
 
 
 
 
Net Income-40.4M-85.2M-72.0M-53.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.6M29.0M31.3M37.2M
 
 
 
 
 
Shares To Calculate EPS Diluted28.6M29.0M31.3M37.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.41-$2.94-$2.30-$1.44
 
 
 
 
 
EPS Diluted-$1.41-$2.94-$2.30-$1.44